JAZZ – jazz pharmaceuticals plc - ordinary shares (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

JAZZ

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/25

07:31 am

jazz

Jazz Pharmaceuticals (NASDAQ:JAZZ) was downgraded by analysts at UBS Group AG from a "strong-buy" rating to a "hold" rating.

Low Report

Jazz Pharmaceuticals (NASDAQ:JAZZ) was downgraded by analysts at UBS Group AG from a "strong-buy" rating to a "hold" rating.

Report

11/24

08:27 am

jazz

Rating for JAZZ

Low Report

Rating for JAZZ

Report

11/24

07:19 am

jazz

Jazz Pharmaceuticals (NASDAQ:JAZZ) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating.

Low Report

Jazz Pharmaceuticals (NASDAQ:JAZZ) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating.

Report

11/24

06:25 am

jazz

Jazz Pharmaceuticals downgraded to Neutral from Buy at UBS

Low Report

Jazz Pharmaceuticals downgraded to Neutral from Buy at UBS

Report

11/18

02:20 pm

jazz

Rating for JAZZ

Low Report

Rating for JAZZ

Report

11/18

02:20 pm

jazz

Rating for JAZZ

Low Report

Rating for JAZZ

Report

11/18

10:25 am

jazz

Rating for JAZZ

Low Report

Rating for JAZZ

Report

11/18

10:25 am

jazz

Rating for JAZZ

Low Report

Rating for JAZZ

Report

11/17

12:36 pm

jazz

Rating for JAZZ

Low Report

Rating for JAZZ

Report

11/17

12:36 pm

jazz

Rating for JAZZ

Low Report

Rating for JAZZ

Report

11/6

11:14 am

jazz

Rating for JAZZ

Low Report

Rating for JAZZ

Report

11/6

11:14 am

jazz

Rating for JAZZ

Low Report

Rating for JAZZ

Report

10/27

10:32 am

jazz

Rating for JAZZ

Low Report

Rating for JAZZ

Report

10/20

11:35 am

jazz

Rating for JAZZ

Low Report

Rating for JAZZ

Report

10/20

11:35 am

jazz

Rating for JAZZ

Low Report

Rating for JAZZ

Report

10/20

08:21 am

jazz

Jazz Pharmaceuticals (NASDAQ:JAZZ) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.

Low Report

Jazz Pharmaceuticals (NASDAQ:JAZZ) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.

Report

10/20

08:21 am

jazz

Jazz Pharmaceuticals (NASDAQ:JAZZ) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.

Low Report

Jazz Pharmaceuticals (NASDAQ:JAZZ) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.

Report

9/24

09:24 am

jazz

Rating for JAZZ

Report

Rating for JAZZ

Report

9/24

09:24 am

jazz

Rating for JAZZ

Report

Rating for JAZZ

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.